- Yáñez-Mó M:
-
Unidad de Investigación, Hospital Sta Cristina, Instituto de Investigaciones Sanitarias Princesa (IIS-IP), Madrid, Spain
Departamento de Biología Molecular, UAM, Madrid, Spain
- Siljander PR:
-
Extracellular Vesicle Research, Division of Biochemistry and Biotechnology, Department of Biosciences, University of Helsinki, Helsinki, Finland
Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
- Andreu Z:
-
Unidad de Investigación, Hospital Sta Cristina, Instituto de Investigaciones Sanitarias Princesa (IIS-IP), Madrid, Spain
- Zavec AB:
-
Laboratory for Molecular Biology and Nanobiotechnology, National Institute of Chemistry, Ljubljana, Slovenia
- Borràs FE:
-
IVECAT Group - "Germans Trias i Pujol" Research Institute, Badalona, Spain
Nephrology Service - "Germans Trias i Pujol" University Hospital, Badalona, Spain
- Buzas EI:
-
Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
- Buzas K:
-
Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary
Faculty of Dentistry, University of Szeged, Szeged, Hungary
- Casal E:
-
Metabolomics Unit, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio, Spain
- Cappello F:
-
Department of Experimental Biomedicine and Clinical Neuroscience, Human Anatomy Section, University of Palermo, Palermo, Italy
Euro-Mediterranean Institute of Science and Technology, Palermo, Italy
- Carvalho J:
-
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Expression Regulation in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
- Colás E:
-
Research Unit in Biomedicine and Translational Oncology, Vall Hebron Institute of Research and Autonomous University of Barcelona, Barcelona, Spain
- Cordeiro-da Silva A:
-
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
- Fais S:
-
Anti-Tumour Drugs Section, Department of Therapeutic Research and Medicines Evaluation, National Institute of Health (ISS), Rome, Italy
- Falcon-Perez JM:
-
Metabolomics Unit, CIC bioGUNE, CIBERehd, Bizkaia Technology Park, Derio, Spain
IKERBASQUE, Basque Foundation for Science, Bilbao, Spain
- Ghobrial IM:
-
Dana-Farber Cancer Institute, Boston, MA, USA
- Giebel B:
-
Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
- Gimona M:
-
Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria
Department of Blood Group Serology and Transfusion Medicine, Universitätsklinikum, Salzburger Landeskliniken GesmbH (SALK), Salzburg, Austria
- Graner M:
-
Department of Neurosurgery, University of Colorado Denver, CO, USA
- Gursel I:
-
Department of Molecular Biology and Genetics, Thorlab-Therapeutic Oligonucleotide Research Lab, Bilkent University, Ankara, Turkey
- Gursel M:
-
Department of Biological Sciences, Middle East Technical University, Ankara, Turkey
- Heegaard NH:
-
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, University of Southern Denmark, Odense, Denmark
Analytical Protein Chemistry, Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark
- Hendrix A:
-
Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium
- Kierulf P:
-
Bood Cell Research Group, Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway
- Kokubun K:
-
Dana-Farber Cancer Institute, Boston, MA, USA
- Kosanovic M:
-
Department of Immunochemistry and Glycobiology, Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Belgrade, Serbia
- Kralj-Iglic V:
-
Laboratory of Clinical Biophysics, Faculty of Health Sciences, University of Ljubljana, Ljubljana, Slovenia
- Krämer-Albers EM:
-
Molecular Cell Biology and Focus Program Translational Neurosciences, University of Mainz, Mainz, Germany
- Laitinen S:
-
Research and Cell Services, Finnish Red Cross Blood Service, Helsinki, Finland
- Lässer C:
-
Krefting Research Centre, Institute of Medicine at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Lener T:
-
Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria
Department of Blood Group Serology and Transfusion Medicine, Universitätsklinikum, Salzburger Landeskliniken GesmbH (SALK), Salzburg, Austria
- Ligeti E:
-
Department of Physiology, Semmelweis University, Budapest, Hungary
- Line A:
-
Latvian Biomedical Research and Study Centre, Riga, Latvia
- Lipps G:
-
Institute of Chemistry and Bioanalytics, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
- Llorente A:
-
Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway
- Lötvall J:
-
Krefting Research Centre, Institute of Medicine at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- Mancek-Keber M:
-
National Institute of Chemistry, Laboratory of Biotechnology, Ljubljana, Slovenia
EN?FIST Centre of Excellence, Ljubljana, Slovenia
- Marcilla A:
-
Departamento de Biología Celular y Parasitologia, Facultat de Farmacia, Universitat de Valencia, Valencia, Spain
- Mittelbrunn M:
-
Department of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
- Nazarenko I:
-
Institute for Environmental Health Sciences and Hospital Infection ControlMedical Center - University of Freiburg, Freiburg im Breisgau, Germany
- Nyman TA:
-
Institute of Biotechnology, (Viikinkaari 1), University of Helsinki, Helsinki, Finland
- O'Driscoll L:
-
School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
- Olivan M:
-
Research Unit in Biomedicine and Translational Oncology, Vall Hebron Institute of Research and Autonomous University of Barcelona, Barcelona, Spain
- Oliveira C:
-
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Expression Regulation in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Pathology and Oncology, Faculty of Medicine, University of Porto, Porto, Portugal
- Pállinger É:
-
Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
- Del Portillo HA:
-
ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
Institució Catalana de Recerca I Estudis Avançats, Barcelona, Spain
- Reventós J:
-
Research Unit in Biomedicine and Translational Oncology, Vall Hebron Institute of Research and Autonomous University of Barcelona, Barcelona, Spain
Departament de Ciències Bàsiques, Universitat Internacional de Catalunya, and Institut de Recerca Biomèdica de Bellvitge, Barcelona, Spain
- Rigau M:
-
Research Unit in Biomedicine and Translational Oncology, Vall Hebron Institute of Research and Autonomous University of Barcelona, Barcelona, Spain
- Rohde E:
-
Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria
Department of Blood Group Serology and Transfusion Medicine, Universitätsklinikum, Salzburger Landeskliniken GesmbH (SALK), Salzburg, Austria
- Sammar M:
-
Department of Biotechnology Engineering, ORT Braude College, Karmiel, Israel
- Sánchez-Madrid F:
-
Department of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
Servicio de Inmunología, Hospital de la Princesa, Instituto de Investigaciones Sanitarias Princesa (IIS-IP), Madrid, Spain
- Santarém N:
-
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
- Schallmoser K:
-
Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria
Department of Blood Group Serology and Transfusion Medicine, Universitätsklinikum, Salzburger Landeskliniken GesmbH (SALK), Salzburg, Austria
- Ostenfeld MS:
-
Departmnet of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
- Stukelj R:
-
Laboratory of Clinical Biophysics, Faculty of Health Sciences, University of Ljubljana, Ljubljana, Slovenia
- Vasconcelos MH:
-
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
Cancer Drug Resistance Group, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Department of Biological Sciences, Faculty of Pharmacy, University of Porto (FFUP), Porto, Portugal
- De Wever O:
-
Laboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium